MedTrace Logo

Randomized Clinical Trial Assessing Laryngeal Mask Airway Versus Face-mask Ventilation in Neonatal Resuscitation

NCT02042118 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-02-01

No results posted yet for this study

Summary

The purpose of this study is to compare the use of a laryngeal mask airway (LMA) vs. face-mask ventilation (FMV) during first-line neonatal resuscitation in Mulago Hospital, Kampala, Uganda.

Conditions

  • Asphyxia Neonatorum

Interventions

DEVICE

Laryngeal Mask Airway

Laryngeal mask airway (LMA) ventilation will be provided for newborns in this arm during the first 2.5 minutes.

DEVICE

Face mask ventilation

Face-mask ventilation (FMV) will be provided for newborns in this arm during the first 2.5 minutes.

Sponsors & Collaborators

  • Makerere University

    collaborator OTHER

  • Centre For International Health

    lead OTHER

Principal Investigators

  • Thorkild Tylleskar, MD, PhD · Centre for International Health, University of Bergen

  • Nicolas J Pejovic, MD · Centre for International Health, University of Bergen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
1 Hour
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-05-31
Completion
2016-12-31

Countries

  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02042118 on ClinicalTrials.gov